Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Erythromycin Patent Expiration

Erythromycin was first introduced by Westwood Squibb Pharmaceuticals Inc in its drug Staticin on Approved Prior to Jan 1, 1982. Other drugs containing Erythromycin are Ilotycin, Erythromycin, Pce, Erygel, Akne-Mycin, Eryc Sprinkles, Eryc, Erycette. 45 different companies have introduced drugs containing Erythromycin.


About Veterinary Erythromycin

Erythromycin is used in drugs marketed by 2 different companies: Bimeda Animal Health Limited, Zoetis Inc.

Other drugs containing Erythromycin are: Gallimycin injection, gallimycin 100 , Gallimycin 36 , Erythromast 36 , Erythro 100 injection

Erythromycin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Erythromycin Generic API Manufacturers

Several generic applications have been filed for Erythromycin. The first generic version for Erythromycin was by Dista Products Co Div Eli Lilly And Co and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Abon Pharmaceuticals Llc and was approved on Sep 23, 2025.

Given below is the list of companies who have filed for Erythromycin generic, along with the locations of their manufacturing plants worldwide.